- Review
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
- Tadahiro Shoji,
- Chie Sato,
- Hidetoshi Tomabechi,
- Eriko Takatori,
- Yoshitaka Kaido,
- Takayuki Nagasawa,
- Masahiro Kagabu and
- Tsukasa Baba
The incidence of ovarian cancer, which has had a poor prognosis, is increasing annually. Currently, the prognosis is expected to improve with the use of molecular-targeted drugs and immune checkpoint inhibitors as maintenance therapies after the firs...

